Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
115180 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115180002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 242, C동 8층, 성남시
- Website:
- http://www.qurient.com/
Description
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-29 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 102.2 KB | ||
| 2024-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 32.3 KB | ||
| 2024-11-29 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 124.4 KB | ||
| 2024-11-22 00:00 |
증권발행결과(자율공시) (제2회차 CB)
|
Korean | 6.1 KB | ||
| 2024-11-19 00:00 |
주요사항보고서(자본으로인정되는채무증권발행결정)
|
Korean | 29.9 KB | ||
| 2024-11-19 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 54.0 KB | ||
| 2024-11-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.3 MB | ||
| 2024-10-29 00:00 |
[기재정정]주식등의대량보유상황보고서(약식)
|
Korean | 71.0 KB | ||
| 2024-10-29 00:00 |
[기재정정]주식등의대량보유상황보고서(약식)
|
Korean | 79.3 KB | ||
| 2024-10-28 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 69.2 KB | ||
| 2024-09-26 00:00 |
임시주주총회결과
|
Korean | 10.9 KB | ||
| 2024-09-10 00:00 |
주주총회소집공고
|
Korean | 76.4 KB | ||
| 2024-09-10 00:00 |
의결권대리행사권유참고서류
|
Korean | 44.8 KB | ||
| 2024-08-27 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (항암치료제 Q901 단독요법 및 병용요법에 대한 식품의약품안전처(MFDS…
|
Korean | 15.0 KB |
Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qurient Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
